EichorEICHOR
Location: Salford Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Salford

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · Salford Royal NHS Foundation Trust · Walden Biosciences · NCT06466135PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Salford Royal · Boehringer Ingelheim · NCT07355296A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Salford Royal NHS Foundation Trust - Salford Royal Hospital · Travere Therapeutics, Inc. · NCT06247085Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Salford Royal Hospital · Amgen · NCT07037433A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Phase 2 · Northern Care Alliance NHS Foundation Trust - Salford Royal · University of Leicester · NCT04663204A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
Phase N/A · Salford Royal · Chiesi Farmaceutici S.p.A. · NCT06663358A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Salford Royal Hospital · Pfizer · NCT05895786Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Proto
Phase 3 · Tanabe Pharma America, Inc. · NCT05005975A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Salford Royal · Boehringer Ingelheim · NCT07220083Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling
NA · Salford Royal · St George's, University of London · NCT04936620Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Phase 3 · Northern Care Alliance NHS Foundation Trust · Dyne Therapeutics · NCT07486934A Global Prospective Observational Registry of Patients With Pompe Disease
Phase N/A · Salford Royal NHS Foundation Trust · Amicus Therapeutics · NCT06121011GEKO Venous Thromboembolism Prevention Study
NA · Salford Royal Hospital · Firstkind Ltd · NCT05476913Natural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA)
Phase N/A · Travere Investigational Site · Travere Therapeutics, Inc. · NCT02998710A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Phase 2 · Northern Care Alliance NHS Foundation Trust - Salford Royal · Vertex Pharmaceuticals Incorporated · NCT07501702A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Phase 3 · Salford Care Organisation · Dimerix Bioscience Pty Ltd · NCT05183646A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Phase 3 · Salford Royal Hospital · argenx · NCT07091630Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)
Phase N/A · Salford Royal Hospital · University Hospital Southampton NHS Foundation Trust · NCT06440174Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Phase 3 · Salford Royal Hospital · The University of Queensland · NCT04939935Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Phase N/A · Salford Royal Hospital, Salford Royal NHS Foundation Trust · University of Leeds · NCT04102930Adult SMA Research and Clinical Hub
Phase N/A · The Northern Care Alliance NHS Foundation Trust · Newcastle-upon-Tyne Hospitals NHS Trust · NCT06978985OptiMuscle - Improving Respiration by Optimising Muscle Function
NA · University of Salford · NCT06103955A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Phase 2 · Salford Royal Hospital · PepGen Inc · NCT06667453Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System A
Phase 1 · Salford Royal Hospital · Ionis Pharmaceuticals, Inc. · NCT04165486A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urt
Phase 3 · Celldex Therapeutics · NCT07266402PS-002 for the Treatment of IgA Nephropathy in Adults
Phase 1/Phase 2 · Purespring Therapeutics Limited · NCT07182227A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' D
Phase 2 · Site Number - 7010 · Immunovant Sciences GmbH · NCT07018323Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
Phase 2/Phase 3 · Clinical Research Facility Salford Royal NHS Foundation Trus · University of Edinburgh · NCT04302870
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.